2015

Bringing You Full Social Media Visibility with Treato IQ
June 23, 2015


Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
June 18, 2015


Advanced Cell Diagnostics and Indica Labs Partner to Provide Quantitative RNA ISH Analysis Through ACD’s Pharma Assay Services
June 15, 2015


Tioga Pharmaceuticals Announces Initiation of Phase 2 Clinical Study of Asimadoline in Patients with Pruritus Associated with Atopic Dermatitis
June 11, 2015


Unum Therapeutics Announces $65 Million Series B Financing Round
June 11, 2015


Oxford Immunotec Announces First Patient Enrolled in REACT Trial for T-SPOT.CMV
June 11, 2015


Intarcia’s Kurt Graves Named an EY Entrepreneur Of The Year® 2015
June 5, 2015


VaxInnate Advances Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, into Phase 2 Study
June 3, 2015


Spiracur Expands Global Reach with the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System
June 2, 2015


Edge Therapeutics Completes Enrollment in Phase 1/2 NEWTON Study of EG-1962 for Patients with Ruptured Brain Aneurysm
May 28, 2015


Kit Check Tracks Five Million Hospital Medications with RFID and Cloud Software Solution
May 28, 2015


Oxford Immunotec Announces CE Mark Approval for T-SPOT.CMV Test
April 27th, 2015


Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing with Equity Conversion Option at $5.5 Billion Valuation
April 27, 2015


Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors
April 27, 2015


Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring
April 21, 2015


Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing
April 21, 2015


TigerText Introduces First Secure Enterprise Messaging App for the Apple Watch
April 14, 2015


Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency
April 13, 2015


Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330)
April 13, 2015


Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings
April 9, 2015


Group Message Confirmations Are Here! (TigerText)
April 9, 2015


Amerinet Offers Kit Check to 3,000 Member Hospitals
April 7, 2015


Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States
March 31, 2015


CardioKinetix Announces Excellent Results of Chinese Trial Evaluating Parachute Heart Failure Device
March 24, 2015


Intarcia and Numab Sign Multi-Asset Collaboration to Develop Once-Yearly Therapies in Diabetes, Obesity, and Autoimmune Indications
March 19, 2015


Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefit Costs
March 17, 2015


Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session
March 14, 2015


TigerText Launches TigerConnect Secure Messaging Platform
March 3, 2015


VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines
February 17, 2015


Oxford Immunotec Global PLC Announces Pricing of Underwritten Offering of Ordinary Shares
January 30, 2015


Versartis Announces Pricing of Follow-On Offering
January 21, 2015


Kit Check Raises $12 Million Series B
January 12, 2015


Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
January 12, 2015


Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals
January 11, 2015


Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test
January 6, 2015


Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension
January 5, 2015


Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study
January 5, 2015